---
title: "Jacobio Pharmaceuticals files HKEX disclosure return reporting share repurchase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292630519.md"
description: "Jacobio Pharmaceuticals filed a disclosure with the HKEX reporting the repurchase of 102,000 shares for treasury on July 14, 2026. The buyback occurred at a price range of HKD 4.87 to HKD 4.92 per share, with an aggregate consideration of HKD 498,840. No shares were cancelled during this transaction."
datetime: "2026-07-14T13:02:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292630519.md)
  - [en](https://longbridge.com/en/news/292630519.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292630519.md)
generator: "portal-rs"
---

# Jacobio Pharmaceuticals files HKEX disclosure return reporting share repurchase

-   Jacobio Pharmaceuticals filed a next-day disclosure return showing a buyback of 102,000 shares on July 14, 2026 for treasury. \* Repurchase price range HKD 4.87 to HKD 4.92; aggregate consideration HKD 498,840. \* Total repurchased/cancelled shares: 102,000 repurchased; 0 cancelled. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260714-12244296), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Consun Pharmaceutical Declares Interim Cash Dividend for First Half of 2026](https://longbridge.com/en/news/296986586.md)
- [Kuaishou files HKEX next-day return, share capital rises by 4,037 shares](https://longbridge.com/en/news/297178043.md)
- [SSY Group declares interim dividend of HKD 0.055 per share](https://longbridge.com/en/news/297021986.md)
- [Kuaishou files next-day disclosure return in Hong Kong after 7,079-share capital increase](https://longbridge.com/en/news/296902200.md)
- [Orion starts buyback of up to 500,000 Class B shares for employee incentive plans, sets EUR 45 million cap](https://longbridge.com/en/news/297162340.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**